Peter Buhl Hjortrup

196 posts

Peter Buhl Hjortrup

Peter Buhl Hjortrup

@pbhjortrup

MD PhD researcher/clinician with special interest in intensive care and septic shock... CLASSIC trial management committee. YNWA

Copenhagen, Denmark Katılım Mayıs 2014
213 Takip Edilen328 Takipçiler
Peter Buhl Hjortrup retweetledi
Intensive Care Medicine
Intensive Care Medicine@yourICM·
#COVID19 cardiovascular impact in critically ill ➡️pathophysiology behind increased long term risk? ➡️trajectory of US findings? ➡️influence of vaccines/immunomodulatory drugs? ➡️role for prophylaxis? 📖bit.ly/3sqc2Xx Refers to ECHO-COVID study 📖rdcu.be/cNgIu
Intensive Care Medicine tweet media
English
1
29
46
0
Peter Buhl Hjortrup retweetledi
Critical Care Reviews
Critical Care Reviews@CritCareReviews·
One of the most outstanding questions in critical care is whether patients benefit from IV fluid resuscitation in septic shock. A thread... (image shutterstock) 1/16
Critical Care Reviews tweet media
English
10
289
828
0
Peter Buhl Hjortrup retweetledi
Critical Care Reviews
Critical Care Reviews@CritCareReviews·
The unedited videos of the first 2 days of #eCCR21 are now available on the (temporary...) website. I'll get the edited versions up as quick as I can ccrtestsite.com
Critical Care Reviews tweet media
English
2
34
76
0
Peter Buhl Hjortrup retweetledi
Critical Care Reviews
Critical Care Reviews@CritCareReviews·
Just 9 weeks to eCCR21. We start to release the programme this week. Just the 5 major trial results to be hosted, 11 of the best critical care trials of 2020 to be presented by their chief investigators, plus a little more... All freely live streamed. #eCCR21
Critical Care Reviews tweet media
English
1
43
112
0
Peter Buhl Hjortrup retweetledi
Intensive Care Medicine
Intensive Care Medicine@yourICM·
#ICU pts receive vast amounts of IV fluids: choosing right solution/volume to avoid harm challenging. Design/conduction of trials complex, lot of unanswered questions: debates not likely to end soon but each high-quality trial is small step toward solution rdcu.be/b6kQD
Intensive Care Medicine tweet media
English
1
55
113
0
Peter Buhl Hjortrup retweetledi
CRIC
CRIC@CRIC_Int_Care·
Good news in the midst of the pandemic. The CLASSIC trial is halfway! Thanks a million to clinical staff, relatives and patients! Trial results will improve outcomes of septic shock. @AndersPerner @TineMeyhoff @pbhjortrup @MortenHylander @Majkja
CRIC tweet media
English
0
5
15
0
Nico Pavez
Nico Pavez@malignuss·
@CovidSteroid Great! Any already trial protocol already submitted? Good luck 🍀👍🏼
English
1
0
1
0
covid steroid
covid steroid@CovidSteroid·
Four Danish sites have randomised patients in the COVID STEROID Trial. Now 6 patients have been enrolled and 994 to go. Another 13 Danish sites are ready to randomise their first patients. More knowledge of steroids are coming up for these critically ill patients with COVID-19.
English
1
11
27
0
Peter Buhl Hjortrup retweetledi
Giuseppe Citerio
Giuseppe Citerio@Dr_Cit·
The Surviving Sepsis Campaign guidelines for severe #COVID19 in ICU under review at @yourICM will be available probably before the weekend on the @ESICM website as pre-proof document.
Giuseppe Citerio tweet media
English
2
122
251
0
Peter Buhl Hjortrup retweetledi
scanFOAM
scanFOAM@scanfoam·
Don't forget you can enjoy free talks on cardiac arrest management from world exports over breakfast scanfoam.org/bigsick20/ #FOAMed
English
0
7
9
0